Last April, the FDA ordered compounding pharmacies to stop producing copycat weight-loss drugs, but sales have continued
Cases involving diagnosed gastroparesis, bowel obstruction, gallbladder surgery, or documented NAION-related vision loss are generally expected to carry higher projected values than cases involving temporary or less severe complications
Post-marketing surveillance data spanning over a decade of GLP-1 medicine use have not identified an increased signal for thyroid malignancy
The Adaptation Protocol Weeks 1 to 4: Reduce training volume by 30 percent
Yet, Schoretsanitis clarified that their findings absolutely do not mean that someone taking antidepressants should not take semaglutide or other GLP-1 drugs
If you are trying to access this site from the United States, please try heading to our homepage or our drug directory